CodeLab Capital AS (OSL:CODE)
Norway · Delayed Price · Currency is NOK 2.950
+0.100 (3.51%)
Aug 15, 2025, 4:10 PM CET
CodeLab Capital AS Revenue
In the year 2024, CodeLab Capital AS had annual revenue of 249.39K NOK, down -99.58%. CodeLab Capital AS had revenue of 79.10K in the quarter ending December 31, 2024, a decrease of -94.34%.
Revenue
249.39K
Revenue Growth
-99.58%
P/S Ratio
153.04
Revenue / Employee
8.91K
Employees
28
Market Cap
38.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 249.39K | -58.92M | -99.58% |
| Dec 31, 2023 | 59.17M | -135.83M | -69.66% |
| Dec 31, 2022 | 195.01M | -13.63M | -6.53% |
| Dec 31, 2021 | 208.63M | 68.85M | 49.26% |
| Dec 31, 2020 | 139.78M | 24.97M | 21.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 522.86M |
| ArcticZymes Technologies ASA | 104.33M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |